Search Result

Results for "

SF1

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Linker (2) AMPK (6) Apoptosis (6) Autophagy (6) DNA/RNA Synthesis (1) Drug-Linker Conjugates for ADC (1) Isotope-Labeled Compounds (2) MicroRNA (1) Mitophagy (6) mTOR (6) Orphan Nuclear Receptor (10) Reference Standards (2) Small Interfering RNA (siRNA) (9) Transmembrane Glycoprotein (1)
By Research Areas:	Cancer (18) Cardiovascular Disease (6) Endocrinology (3) Infection (2) Inflammation/Immunology (4) Metabolic Disease (8) Neurological Disease (2)
Oligonucleotides:	Rat Pre-designed siRNA Sets (3) Mouse Pre-designed siRNA Sets (3) Human Pre-designed siRNA Sets (3) siRNAs (9)

Inhibitors & Agonists

Inhibitory Antibodies

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Targets Recommended: SF3B1

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B0627

Metformin Maximum Cited Publications 196 Publications Verification 1,1-Dimethylbiguanide	AMPK Autophagy Mitophagy Apoptosis mTOR	Cardiovascular Disease Infection Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
Metformin (1,1-Dimethylbiguanide) inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo ^[1] .

HY-17471A

Metformin hydrochloride Maximum Cited Publications 196 Publications Verification 1,1-Dimethylbiguanide hydrochloride	AMPK Autophagy Mitophagy Apoptosis mTOR	Cardiovascular Disease Infection Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
Metformin (1,1-Dimethylbiguanide) hydrochloride inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin hydrochloride exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin hydrochloride also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin hydrochloride regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo ^[1] .

HY-115613

ML-180 5 Publications Verification SR1848	Orphan Nuclear Receptor	Cancer
ML-180 (SR1848) is a potent orphan nuclear receptor *liver receptor homolog 1 (LRH-1; NR5A2)* inverse agonist with an IC₅₀ of 3.7 μM. ML-180 is inactive for steroidogenic factor-1 (SF-1; NR5A1; IC₅₀>10 μM). ML-180 has the potential for LRH-1-dependent cancers ^[1] .

HY-131445

RJW100 1 Publications Verification	MicroRNA	Endocrinology Cancer
RJW100 is a potent *liver receptor homolog 1 (LRH-1, NR5A2)* and steroidogenic factor-1 (SF-1, NR5A1) agonist with pEC₅₀s of 6.6 and 7.5, respectively ^[1]. RJW100 also causes strong activation of the miR-200c (miRNA-200c, microRNA-200c) promoter .

HY-17471AR

Metformin hydrochloride (Standard) 1,1-Dimethylbiguanide hydrochloride (Standard)	Reference Standards AMPK Autophagy Mitophagy Apoptosis mTOR	Cardiovascular Disease Metabolic Disease Cancer
Metformin hydrochloride (Standard) is the analytical standard of Metformin hydrochloride (HY-17471A). This product is intended for research and analytical applications. Metformin (1,1-Dimethylbiguanide) hydrochloride inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin hydrochloride exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin hydrochloride also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin hydrochloride regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo ^[1] .

HY-134462

RJW103	Orphan Nuclear Receptor	Metabolic Disease Cancer
RJW103 is an acid-stable **SF-1 (NR5A1) and LRH-1 agonist with pEC₅₀ values of 6.5 and 5.9, respectively. RJW103 activates SF-1- and LRH-1**-mediated transcription of endogenous target genes. RJW103 can be used in research on cancer, endocrinology and metabolic diseases, such as adrenocortical tumors ^[1] .

HY-107404

SID 7969543	Orphan Nuclear Receptor	Endocrinology
SID 7969543 is a selective *SF-1* (steroidogenic factor 1, NR5A1) inhibitor with an IC₅₀ of 760 nM. SID 7969543 inhibits SF-1-triggered luciferase expression with IC₅₀ of 30 nM. SF-1 is a transcription factor belonging to the nuclear receptor superfamily ^[1] .

HY-148259

SF-1 antagonist-1	Orphan Nuclear Receptor	Cancer
SF-1 antagonist-1 (compound 11) is a antagonist of steroidogenic factor 1 (SF-1). SF-1 antagonist-1 affects SF-1 transcriptional activity with an EC₅₀ value of ＜200 nM. SF-1 antagonist-1 inhibits the proliferation of Rat Leydig tumor cells. SF-1 antagonist-1 can be used for the research of cancer ^[1].

HY-131445B

RR-RJW100 1 Publications Verification	Orphan Nuclear Receptor	Metabolic Disease
RR-RJW100, the enantiomer of RJW100, is an nuclear receptor liver receptor homolog 1 (LRH-1) and steroidogenic factor 1 (SF-1) agonist. RJW100 can be synthesized as two enantiomers, RR-RJW100 and SS-RJW100, with RR-RJW100 shown to be the more potent LRH-1 agonist. RR-RJW100 is involved in the regulation of metabolic homeostasis and is used in studies of diabetes, liver disease and inflammatory bowel disease ^[1] .

HY-153736

NSC 194308	DNA/RNA Synthesis	Cancer
NSC 194308, a U2AF2-RNA complexes enhancer, increases association of the U2AF1-U2AF2-SF1-splice site RNA complex by binding a site between the U2AF2 RNA recognition motifs (RRM1 and RRM2). NSC 194308 inhibits pre-mRNA splicing by stalling spliceosome assembly at the point where U2AF helps recruit U2 snRNP to the branchpoint. NSC 194308 enhances the binding of pre-mRNA to U2AF2, selectively triggering cell death in leukemia cell lines containing spliceosome mutations ^[1].

HY-B0627S

Metformin-d6 1,1-Dimethylbiguanide-d₆	Isotope-Labeled Compounds AMPK Autophagy Mitophagy Apoptosis mTOR	Cardiovascular Disease Cancer
Metformin-d₆ (1,1-Dimethylbiguanide-d₆) is a deuterated labeled Metformin (HY-B0627). Metformin (1,1-Dimethylbiguanide) inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo ^[1] .

HY-134462A

RJW103 TFA	Orphan Nuclear Receptor	Cancer
RJW103 TFA is an acid-stable **SF-1 (NR5A1) and LRH-1 agonist with pEC₅₀ values of 6.5 and 5.9, respectively. RJW103 TFA activates SF-1- and LRH-1**-mediated transcription of endogenous target genes. RJW103 TFA can be used in research on cancer, endocrinology and metabolic diseases, such as adrenocortical tumors ^[1] .

HY-P991187

Anti-TM4SF1 Antibody (AGX-A07) AGX-101 Antibody	Transmembrane Glycoprotein	Cancer
Anti-TM4SF1 Antibody (AGX-A07) is a humanized IgG1 monoclonal antibody that targets *TM4SF1*. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).

HY-RS12756

SF1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
SF1 Human Pre-designed siRNA Set A contains three designed siRNAs for SF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF1 Human Pre-designed siRNA Set A SF1 Human Pre-designed siRNA Set A

HY-129359

PDP-Pfp	ADC Linker	Cancer
PDP-Pfp is a reducible ADC linker used for the agents that target for the extracellular loop 1 (ECL1) of *TM4SF1* (transmembrane 4 L6 family member 1) ^[1].

HY-128207

SID7970631	Orphan Nuclear Receptor	Cancer
SID7970631, as an isoquinolinone analog, is a potent and selective submicromolar *SF-1* inhibitor (IC₅₀=255 nM). SID7970631 can be used for the research of cancer ^[1] .

HY-RS23319

Sf1 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Sf1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sf1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sf1 Rat Pre-designed siRNA Set A Sf1 Rat Pre-designed siRNA Set A

HY-RS16877

Sf1 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Sf1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sf1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sf1 Mouse Pre-designed siRNA Set A Sf1 Mouse Pre-designed siRNA Set A

HY-B0627A

Metformin (glycinate) 1,1-Dimethylbiguanide (glycinate)	AMPK Autophagy Mitophagy Apoptosis mTOR	Cardiovascular Disease Metabolic Disease Cancer
Metformin (1,1-Dimethylbiguanide) glycinate inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin glycinate exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin glycinate also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin glycinate regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo ^[1] .

HY-B0627S1

Metformin-13C2 hydrochloride 1,1-Dimethylbiguanide-13C2 hydrochloride	Isotope-Labeled Compounds AMPK Autophagy Mitophagy Apoptosis mTOR	Cardiovascular Disease Metabolic Disease Cancer
Metformin- ¹³C₂ (1,1-Dimethylbiguanide- ¹³C₂) hydrochloride is the ¹³C-labeled Metformin hydrochloride (HY-17471A). Metformin (1,1-Dimethylbiguanide) hydrochloride inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin hydrochloride exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin hydrochloride also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin hydrochloride regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo ^[1] .

HY-155168

Iso-RJW100	Orphan Nuclear Receptor	Cancer
Iso-RJW100 (compound 24-endo) is a dual-liver receptor homologue-1 (LRH-1) and steroidogenic factor-1 (SF-1) agonist with pEC₅₀ of 6.4 and 7.2, respectively ^[1].

HY-129372

PDdB-Pfp	ADC Linker	Cancer
PDdB-Pfp is a cleavable ADC linker used for the agents that target for the extracellular loop 1 (ECL1) of TM4SF1 (transmembrane 4 L6 family member 1) ^[1].

HY-131445A

SS-RJW100	Orphan Nuclear Receptor	Metabolic Disease Inflammation/Immunology
SS-RJW100 is a enantiomer of RJW100, which is a racemic agonist of nuclear receptor liver receptor homolog 1 (LRH-1) and steroidogenic factor 1 (SF-1). SS-RJW100 promotes recruitment of coregulator protein fragments in vitro, recruits the transcriptional intermediary factor 2 (Tif2) coactivator to LRH-1. SS-RJW100 diminishes LRH-1 allosteric activation networks, shows poor thermal stability ^[1] .

HY-107404R

SID 7969543 (Standard)	Reference Standards Orphan Nuclear Receptor	Endocrinology
SID 7969543 (Standard) is the analytical standard of SID 7969543 (HY-107404). This product is intended for research and analytical applications. SID 7969543 is a selective SF-1 (steroidogenic factor 1, NR5A1) inhibitor with an IC₅₀ of 760 nM. SID 7969543 inhibits SF-1-triggered luciferase expression with IC₅₀ of 30 nM. SF-1 is a transcription factor belonging to the nuclear receptor superfamily ^[1] .

HY-RS14606

TM4SF1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TM4SF1 Human Pre-designed siRNA Set A contains three designed siRNAs for TM4SF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TM4SF1 Human Pre-designed siRNA Set A TM4SF1 Human Pre-designed siRNA Set A

HY-RS09553

NR5A1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
NR5A1 Human Pre-designed siRNA Set A contains three designed siRNAs for NR5A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR5A1 Human Pre-designed siRNA Set A NR5A1 Human Pre-designed siRNA Set A

HY-RS26317

Tm4sf1 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Tm4sf1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tm4sf1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tm4sf1 Rat Pre-designed siRNA Set A Tm4sf1 Rat Pre-designed siRNA Set A

HY-RS19821

Tm4sf1 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Tm4sf1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tm4sf1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tm4sf1 Mouse Pre-designed siRNA Set A Tm4sf1 Mouse Pre-designed siRNA Set A

HY-RS17509

Nr5a1 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Nr5a1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nr5a1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nr5a1 Mouse Pre-designed siRNA Set A Nr5a1 Mouse Pre-designed siRNA Set A

HY-RS23966

Nr5a1 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Nr5a1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nr5a1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nr5a1 Rat Pre-designed siRNA Set A Nr5a1 Rat Pre-designed siRNA Set A

HY-167960

BrAc-Galactose-Sar-N-Me-alanine-DM1	Drug-Linker Conjugates for ADC	Cancer
BrAc-Galactose-Sar-N-Me-alanine-DM1 (compound 11) is a drug-linker conjugate for ADC, which can be conjugated with the anti-TM4SF1 antibody (e.g., AGX-A07 (HY-P991187) for the synthesis of ADC ^[1].

Cat. No.	Product Name	Target	Research Area	Image

HY-P990521

Anti-TM4SF1 Antibody	Inhibitory Antibodies	Inflammation/Immunology
The Anti-TM4SF1 Antibody is a CHO-expressed human antibody that targets *TM4SF1. The Anti-TM4SF1 Antibody is equipped with a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for the Anti*-TM4SF1 Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P991187

Anti-TM4SF1 Antibody (AGX-A07) AGX-101 Antibody	Transmembrane Glycoprotein	Cancer
Anti-TM4SF1 Antibody (AGX-A07) is a humanized IgG1 monoclonal antibody that targets *TM4SF1*. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).

Species:	Human (2) Cynomolgus (1)
Tag:	His (2) Tag Free (1) Strep (1)
Source:	HEK293 (2) E. coli (1)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P703128

	NR5A1 Protein, Human (His, Strep) AD4BP; FTZF1; SF1	Human	E. coli
	NR5A1 Protein, Human (His, Strep) is the recombinant human-derived NR5A1, expressed by E. coli , with Strep, His labeled tag. ,

HY-P700837

	TM4SF1 Protein-VLP, Human (HEK293) M3S1; TAAL6; H-L6; L6	Human	HEK293
	TM4SF1 Protein-VLP, Human (HEK293) is recommended for animal immunization, ELISA, PK assay. If VLP control is required, it is recommended HY-P702775. May have binding signals with Anti-His antibodies.

HY-P702595

	TM4SF1 Protein-VLP, Cynomolgus (HEK293, His) M3S1; TAAL6; H-L6; L6	Cynomolgus	HEK293
	TM4SF1 Protein-VLP, Cynomolgus (HEK293, His) is recommended for animal immunization, ELISA. It is not recommended for receptor-ligand interaction detection and SPR/BLI assay since there are other irrelevant membrane proteins of the host on the VLP envelope, and the receptor-ligand interaction will have strong background interference. High requirements for chips and experimental protocols are needed for SPR/BLI assays. If VLP control is required, it is recommended HY-P701236. Tags can only be detected under denaturing conditions.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-B0627S

Metformin-d6
Metformin-d₆ (1,1-Dimethylbiguanide-d₆) is a deuterated labeled Metformin (HY-B0627). Metformin (1,1-Dimethylbiguanide) inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo ^[1] .

Metformin-d6

Metformin-d₆ (1,1-Dimethylbiguanide-d₆) is a deuterated labeled Metformin (HY-B0627). Metformin (1,1-Dimethylbiguanide) inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo ^[1] .

HY-B0627S1

Metformin-13C2 hydrochloride
Metformin- ¹³C₂ (1,1-Dimethylbiguanide- ¹³C₂) hydrochloride is the ¹³C-labeled Metformin hydrochloride (HY-17471A). Metformin (1,1-Dimethylbiguanide) hydrochloride inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin hydrochloride exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin hydrochloride also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin hydrochloride regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo ^[1] .

Metformin-13C2 hydrochloride

Metformin- ¹³C₂ (1,1-Dimethylbiguanide- ¹³C₂) hydrochloride is the ¹³C-labeled Metformin hydrochloride (HY-17471A). Metformin (1,1-Dimethylbiguanide) hydrochloride inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin hydrochloride exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin hydrochloride also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin hydrochloride regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo ^[1] .

Host:	Mouse (3) Rabbit (2)
Reactivity:	Human (5) Rat (2) Mouse (3)
Application:	IHC-P (4) ICC/IF (1) IP (1) WB (2)
Isotype:	IgG (2) IgG1 (2) IgG2 (1)
Conjugation:	Non-conjugated (5)
Clonality:	Monoclonal (4) Recombinant (2)
Modification:	Unmodified (4)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P83141

	*Tat SF1* Antibody (YA2886)** HTATSF1; HTSF1; TAT SF1	WB, IHC-P, ICC/IF, IP	Human, Mouse
	Tat SF1 Antibody (YA2886) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Tat SF1.

HY-P83421

	Steroidogenic Factor 1 Antibody (YA3166) AD4BP; ELP; FTZ1; FTZF1; hSF 1; NR5A1; POF7; SF1; SPGF8; SRXY3; STF1; SF-1	WB	Human, Mouse, Rat
	Steroidogenic Factor 1 Antibody (YA3166) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Steroidogenic Factor 1.

HY-P89089

	SF1 Antibody (YA8773) BBP; D11S636; MBBP; ZCCHC25; ZFM1; ZNF162	IHC-P	Human
	SF1 Antibody (YA8773) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to SF1.

HY-P89089A

	SF1 Antibody (YA8773)(PBS only) BBP; D11S636; MBBP; ZCCHC25; ZFM1; ZNF162	IHC-P	Human
	SF1 Antibody (YA8773) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to SF1.

HY-P810352

	Steroidogenic Factor 1 Antibody (YA9674) AD4BP, ELP, FTZ1, FTZF1, hSF-1, POF7, SF-1, SF1, SPGF8, SRXY3	IHC-P	Human, Mouse, Rat
	Steroidogenic Factor 1 Antibody (YA9674) is a Mouse-derived and non-conjugated IgG2 Monoclonal antibody, targeting to Steroidogenic Factor 1.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: